| Authors: |
Wilson WH; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA., Young RM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA., Schmitz R; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA., Yang Y; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA., Pittaluga S; Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, Maryland, USA., Wright G; Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA., Lih CJ; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Shaffer AL; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA., Gerecitano J; 1] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. [2] Department of Medicine, Weill Cornell Medical College, New York, New York, USA., de Vos S; Division of Hematology and Oncology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, USA., Goy A; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, New Jersey, USA., Kenkre VP; Division of Hematology and Medical Oncology, University of Wisconsin, Madison, Wisconsin, USA., Barr PM; James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, USA., Blum KA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA., Shustov A; Department of Medicine, Hematology, University of Washington School of Medicine, Seattle, Washington, USA., Advani R; Medical Oncology, Stanford University Medical Center, Stanford, California, USA., Fowler NH; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vose JM; Division of Hematology &Oncology, Department of Internal Medicine, University of Nebraska, Omaha, Nebraska, USA., Elstrom RL; Clinical Development, Genentech, Inc., South San Francisco, California, USA., Habermann TM; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Barrientos JC; Division of Hematology and Medical Oncology, Department of Medicine, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York, USA., McGreivy J; Pharmacyclics, Inc., Sunnyvale, California, USA., Fardis M; Pharmacyclics, Inc., Sunnyvale, California, USA., Chang BY; Pharmacyclics, Inc., Sunnyvale, California, USA., Clow F; Pharmacyclics, Inc., Sunnyvale, California, USA., Munneke B; Pharmacyclics, Inc., Sunnyvale, California, USA., Moussa D; Pharmacyclics, Inc., Sunnyvale, California, USA., Beaupre DM; Pharmacyclics, Inc., Sunnyvale, California, USA., Staudt LM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA. |
